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ABSTRACT  25 
It is well documented that antibiotics have pronounced modulatory effects on the intestinal bacterial 26 
community of both humans and animals, with potential health consequences. The gut microbiota of 27 
mink has however attracted little attention due to low bacterial load and fast gastrointestinal transit 28 
time, questioning its relevance. In the present study we hypothesise that oral amoxicillin treatment 29 
affects the gut microbiota in mink. This was investigated in a controlled trial including 24 animals 30 
of which 12 were treated with amoxicillin for seven days. By applying 16S rRNA gene sequencing 31 
we found that the faecal microbiota was markedly altered already after two days of treatment, with 32 
a surprising increase in diversity to resemble the feed. The diversity within the mucosa at 33 
termination was however reduced, which indicates this compartment as an important colonization 34 
site in mink. No impact on blood biochemistry, lipid metabolism, serum amyloid A, vitamins A and 35 
E and histomorphology of the gut and liver was found, however, a slight decrease in fat digestibility 36 
was observed. We suggest that early life use of amoxicillin in mink production may be 37 
counteractive as dysbiosis of the microbiota during infancy is increasingly being recognized as a 38 
risk factor for future health. 39 
 40 
INTRODUCTION 41 
The rich microbial community residing in the intestinal tract of humans and animals is collectively 42 
termed the gut microbiota. There is a growing body of evidence manifesting that the function of this 43 
gut microbiota is not restricted to general digestion of nutrients in the intestine but also plays a 44 
tremendously important role in relation to general health including programing of the immune 45 
system especially in early life (Matamoros et al. 2013; Albenberg and Wu 2014; Round and 46 
Mazmanian 2014). In addition, the gut microbiota has the capacity to synthesize vitamins B and K 47 
(LeBlanc et al. 2013), deconjugate bile acids (Jones et al. 2008) and produce short chain fatty acids 48 
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and antimicrobial compounds, which overall may limit pathogen colonization and proliferation 49 
(Kamada et al. 2013). Perturbation of the intrinsic balance between the hundreds of different 50 
species within this ecosystem is especially profound following exposure to antimicrobial 51 
compounds and it is well established that oral antibiotic treatment may cause large shifts in 52 
intestinal bacterial community composition in both humans (Panda et al. 2014), rodents (Tulstrup et 53 
al. 2015) and numerous other animals representing both vertebrate- (Grønvold et al. 2010) and 54 
invertebrate species (Raymann, Shaffer and Moran 2016). The effect of antibiotic treatment on the 55 
gut microbiota is highly dependent on the class and spectrum of the drug in question (Tulstrup et al. 56 
2015) and different studies have demonstrated both short- and long-lasting effects of antibiotics not 57 
only on pathogens but also on the resident gut microbiota (Cochetière et al. 2005; Jernberg et al. 58 
2007; Dethlefsen et al. 2008). The extent of the disturbances additionally depends on the dose and 59 
the route of administration as well as the general pharmacokinetic and pharmacodynamic properties 60 
of the drug (Edlund and Nord 2000; Sullivan, Edlund and Nord 2001).  61 
     To date, very few studies have investigated the effects of antibiotics on the gut microbiota in 62 
carnivorous animals (Suchodolski et al. 2009; Grønvold et al. 2010) and to our knowledge, no 63 
studies have specifically investigated the impact of antibiotics on farm mink (Neovison vison). 64 
Recently, high throughput techniques using 16S rRNA gene sequencing of mucosa associated 65 
intestinal samples obtained from mink has showed that the gut microbiota in adult mink is 66 
commonly dominated by bacteria belonging to the phylum Firmicutes (especially the class 67 
Clostridia) with few Bacteroidetes, but may also contain high numbers of both Proteobacteria and 68 
Fusobacteria (Bahl et al. 2017). The dominance of Firmicutes is in accordance with similar studies 69 
sequencing faecal samples from cats and dogs (Handl et al. 2011; Garcia-Mazcorro et al. 2012), 70 
indicating that mink may be a useful animal model for studying other carnivorous animals as well. 71 
Mink have a relatively short intestinal tract and a fast gastro-intestinal transit time of 3-5 hours 72 
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(Bleavins and Aulerich 1981; Szymeczko and Skrede 1990). A bacterial density up to 108 CFU g-1 73 
has been detected in the colon of mink, which is much lower than numbers of bacteria found in 74 
many other mammals including dogs (Davis et al. 1977; Williams, Buddington and Elnif 1998). 75 
Collectively these characteristics could suggest a relatively restricted effect of antibiotics 76 
administered orally on the gut microbiota. 77 
     In Danish mink production, the largest amount of antibiotics is used during the lactation period 78 
in May until August (Chriél et al. 2012; Jensen et al. 2016). At this stage mink kits have a thinner 79 
mucus layer lining the gut wall, different enzyme-related properties in the gastrointestinal tract 80 
(Hedemann, Clausen and Jensen 2011), and a different microbial community composition 81 
compared to adult mink (Williams, Buddington and Elnif 1998) potentially making them more 82 
sensitive than adult animals. The broad-spectrum antibiotic, amoxicillin, is the most frequently used 83 
antibiotic in mink and is utilized for treatment of various infectious diseases including diarrhoea, 84 
urinary tract infections, pneumonia, pleuritis, and abscesses (Pedersen et al. 2009; Chriél et al. 85 
2012). Reports of antimicrobial use in mink in recent years reveal that the oral administration route 86 
constitutes 98% of the antimicrobial use measured in Defined Animal Daily Dose (Jensen et al. 87 
2016). Since oral administration of antimicrobials for mink may involve treatment of either part of 88 
or the entire farm, including both sick and asymptomatic animals, there is a need to understand the 89 
potential impact of the oral antimicrobial administration on the microbiota of the healthy mink gut. 90 
     The present study was designed to investigate the induced changes in the bacterial community 91 
composition of the gut microbiota as well as changes related to biochemical profile, vitamin A and 92 
E levels, lipid metabolism, levels of acute phase reactant serum amyloid A, and histomorphological 93 
parameters in the gut and liver following a standard treatment period of 7 days with daily oral 94 
amoxicillin administered to clinically healthy growing male mink.  95 
 96 
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MATERIALS AND METHODS 97 
Ethical statement 98 
All institutional and national guidelines for the care and use of laboratory animals were followed. 99 
The handling of the animals and the experimental procedures were approved by the Danish Animal 100 
Experiments Inspectorate (licence no. 2016-15-0201-00965) and all personnel involved in handling 101 
and care of the animals were trained for carrying out animal experiments (FELASA certification).  102 
 103 
Animals and housing 104 
The study was carried out at the Danish Fur Breeders Association research farm, Kopenhagen Fur, 105 
Holstebro, Denmark from the 12th to the 26th of September 2016. Twenty-four male mink (Neovison 106 
vison) at 4.5 months of age of the colour type Brown (also referred to as colour type Wild) were 107 
selected for the study. The mink were all littermates in pairs from 12 different litters with a 108 
minimum of 5 kits. The average body mass was 2,809 ± 300 g (mean ± SD) with 584 g as the 109 
maximum body mass variance between siblings. All animals had received standard vaccinations 110 
(Distemink® Vet., Biovet ApS and Biocom-P Vet., Biovet ApS) at the age of 10 weeks and the farm 111 
was tested negative for Aleutian Disease Virus. The mink were housed indoors individually in 112 
metabolic cages modified from Jørgensen, G. & Glem Hansen (1973) with the possibility for 113 
manual ventilation. The average ambient temperature and humidity was 21 ± 1.8ºC and 68.3 ± 114 
4.2%, respectively. All mink were fed 180 g of a diet produced at the local central of feedstuff once 115 
a day in the morning and had free access to tap water. The same batch of feed was used throughout 116 
the entire study.  117 
 118 
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Experimental design 119 
The study was designed as a parallel group experiment. Mink were allocated in two groups by 120 
randomized stratification with one littermate in each group (Fig. 1). Amoxicillin (Octacillin Vet. 121 
800 mg g-1, amoxicillin trihydrate corresponding to 697 mg amoxicillin), 20 mg kg-1 was 122 
administered orally to the treatment group (AMX) from Day 0 and for 7 consecutive days while no 123 
treatment was given to the control group (CON). The antimicrobial compound was mixed in the 124 
feed ration. General health checks were made in the morning and afternoon throughout the study.  125 
 126 
Gastrointestinal transit time  127 
On Day -4 (relative to the antibiotic intervention) a study of the feed transit time was conducted to 128 
verify that the transit time in the gastrointestinal tract (GI-transit time) did not differ between the 129 
two groups before the intervention (Fig. 1). All mink received 100 plastic Hama beads (2.5x2.5 130 
mm, assorted colours, Malte Haaning Plastic A/S), which have been used as a marker of GI-transit 131 
time elsewhere (Hernot et al. 2005). The beads were mixed in 50 g of feed in the morning. When 132 
the 50 g ration was ingested or after one hour the rest of the daily ration without beads was given. 133 
Two hours after beads were ingested the mink started defecating and faeces were collected every 15 134 
minutes. Beads were counted after washing the faeces in a sieve under running water. The time 135 
lapse until the first bead appeared in the faeces was considered the feed transit time for the 136 
individual animal.  137 
  138 
Collection of blood and faeces and biochemical analyses 139 
On Days -5, 2 and 7 blood was obtained by puncture of vena cephalica antebrachii and directly 140 
transferred to EDTA-coated (plasma) and non-coated (serum) tubes (BD Vacutainer Systems, 141 
Preanalytical Solutions, Belliver Industrial Estate, UK). Tubes were centrifuged at 2000 G for 10 142 
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minutes and isolated plasma and serum was transferred to 0.5 ml eppendorf tubes, respectively. 143 
Samples for analysing biochemical parameters in serum as well as parameters related to lipid 144 
metabolism in plasma were kept at 5°C and analysed by Advia® 1800 Clinical Chemistry System, 145 
Siemens, at Centrallaboratoriet, Department of Veterinary and Animal Sciences, University of 146 
Copenhagen, Denmark. Serum samples for analysing acute phase reactant serum amyloid A were 147 
stored at -18°C and analysed by a standard ELISA-kit (Phase SAA assay, Tridelta Development 148 
Ltd., Kildare, Ireland) at the National Veterinary Institute at the Technical University of Denmark. 149 
Plasma samples for analysing vitamin A and E were stored at -18°C and subsequently analysed by 150 
PerkinElmer Series 200 HPLC System at Foulum, University of Aarhus, Denmark (Jensen, Engberg 151 
and Hedemann 1999). 152 
     On Days -5 and 2 faeces was collected from a sterile plastic drape placed under the cages using 153 
disposable forceps and directly transferred to cryovials after voiding (CryoPure Tube 1.8 ml, 154 
SARSTEDT, Germany). Samples were kept on dry ice until they were transferred to storage at -155 
80°C. On Day 7 all mink were euthanized by initial sedation with a mixture of 0.6 ml ketamine 156 
(Ketaminol® Vet. 50 mg ml-1, MSD Animal Health) and medetomidin (Domitor® Vet. 1.0 mg ml-1, 157 
Orion Pharma Animal Health) administered intramuscularly followed by an intracardiac injection 158 
with 1 ml pentobarbital (Euthanimal 200 mg ml-1, corresponding to 182 mg ml-1 pentobarbital, 159 
ScanVet Animal Health A/S).  160 
 161 
Digestibility trial 162 
A digestibility trial was performed on all animals during the intervention period Day 0 – Day 4 163 
(Fig. 1). Total faeces from each animal was collected separately once a day in the morning from 164 
a clean chute placed under the wire cage. The faeces was transferred to an individual foil tray 165 
and stored at -18°C. In addition, feed not consumed was also collected for each animal 166 
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transferred to a foil tray and stored at -18°C. Accumulated feed weighing between 20 and 100 g 167 
at the end of the trial, was analysed for content of dry matter. Faeces and samples of the feed 168 
were analysed for dry matter, protein, fat and ash. Chemical analysis was made in accordance 169 
with EU regulations (Commission Regulation 152/09/EC, 2009) at the analysis laboratory at 170 
Dansk Pelsdyr Foder A/S. Calculations of the apparent digestibility was made in accordance 171 
with existing literature (Ahlstrom & Skrede 1998).  172 
 173 
Dissection of animals 174 
Dissection was performed lege artis immediately after euthanasia. Tissue samples from the liver, 175 
the duodenum as well as the colon and the mesenteric lymph node were removed and transferred to 176 
10% neutral buffered formalin prior to processing for histology. Intestinal content obtained from the 177 
distal colon was collected and stored as described for faecal samples by the use of a disposable 178 
forceps. The collection and storage of mucus (and associated bacteria) was done as previously 179 
described (Bahl et al. 2017). After processing and haematoxylin and eosin staining, liver sections 180 
were graded for hepatic steatosis based on a scoring system applied for classification of non-181 
alcoholic fatty liver disease (Brunt 2007), while the intestine and the mesenteric lymph node were 182 
evaluated in the software programme ZEN 2.3 blue edition (Carl Zeiss microscopy GmbH, 2011, 183 
Göttingen, Germany) after scanning by Zeiss type Axiostar Plus (Carl Zeiss; Göttingen, Germany). 184 
For the section of intestine to be evaluated a minimum of five representative areas on each slide 185 
were to be present.  186 
 187 
Extraction of bacterial community DNA 188 
Total community DNA from mucus, faeces, and feed samples was extracted using the MoBio 189 
Power Soil®-htp 96 Well Soil DNA Isolation Kit (MoBio Laboratories, Carlsbad, CA) according to 190 
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the manufacturer’s recommendations, with minor modifications as previously reported (Tulstrup et 191 
al. 2015). DNA concentrations were measured with the Quant-iT dsDNA HS kit (Life 192 
Technologies). 193 
 194 
Bacterial community composition and diversity 195 
The bacterial community composition was determined by partial 16S rRNA gene sequencing of the 196 
extracted community. DNA amplification of the V3-region was performed following a dual PCR 197 
strategy with universal bacterial primers; PBU (5´-CCTACGGGAGGCAGCAG-3´) and PBR (5´-198 
ATTACCGCGGCTGCTGG-3´) as described previously (Bahl et al. 2017). Sequencing of the 16S 199 
rRNA gene libraries was performed on the Ion OneTouchTM and Ion PGM platform with a 318-200 
Chip v2. Sequencing was performed by the DTU in-house facility (DTU Multi-Assay Core 201 
(DMAC), Technical University of Denmark. Sequencing data were imported into CLC Genomic 202 
Workbench (version 8.5. CLC bio, Qiagen, Aarhus, Denmark) and were de-multiplexed trimmed to 203 
remove barcodes and PCR primers. Quality filtering (maxee 1.5), dereplication, OTU clustering 204 
(minsize 2), chimera filtering (RDP_gold database), mapping of reads to OTUs (97% similarity) 205 
and generation of an OTU table was done according to the UPARSE pipeline (Edgar 2013), 206 
generating a total of 2254 non-chimeric OTUs. Taxonomy was assigned using the RDP 207 
multiclassifier ver. 2.10.1 with a confidence threshold set to 0.5 recommended for sequences shorter 208 
than 250bp (Wang et al. 2007). A phylogenetic tree was created with FastTree  based on PyNAST 209 
alignment of representative OTU sequences with an archaea (Methanosarcina) sequence added as 210 
outgroup for rooting. In QIIME (Caporaso et al. 2010), the OTU table was filtered to exclude OTUs 211 
classified as Cyanobacteria/Chloroplast and to exclude OTUs with average relative abundance 212 
below 0.005% of the total community (Bokulich et al. 2013), resulting in 377 OTUs. Relative taxon 213 
abundances and alpha diversity (Observed OTUs and Shannon diversity index) and beta diversity 214 
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based on unweighted UniFrac distances were calculated in QIIME (core_diversity_analyses.py), 215 
with the sequencing depth rarefied to 4,700 sequences per sample. Sequencing data are deposited in 216 
the NCBI Sequence Read Archive with the accession number SRP110733. 217 
 218 
Data handling and statistics 219 
Statistical analysis was performed in GraphPad Prism (version 7.0b; GraphPad Software Inc., La 220 
Jolla, CA). Differences between groups were assessed by paired t-test, unpaired Student’s t-test or t-221 
test with Welch correction if data had unequal variances. For non-parametric data, Mann-Whitney, 222 
Wilcoxon or Fischer’s exact test were used as appropriate. Levels of biochemical blood parameters 223 
and vitamins were compared between groups on separate days (Day -5, Day 2, and Day 7) as well 224 
as through a trend analysis comparing differences between the sampling days. Levels of acute phase 225 
reactant serum amyloid A, and parameters related to lipid metabolism were compared between the 226 
two groups at the end of the study (Day 7). Statistical significance threshold was set at P < 0.05. 227 
Identification of differentially abundant bacterial taxa based on 16S rRNA gene sequencing was 228 
performed by permutation based tests adjusting for multiple comparisons, with a false discovery 229 
rate threshold q = 0.05 (Pike 2011).  230 
 231 
Results 232 
Effects on the host animals 233 
No morbidity or mortality was recorded during the animal experiment and no gross pathological 234 
findings were recorded in necropsy procedures.  235 
     At Day -4 prior to the intervention, no differences were found in gastro-intestinal transit time 236 
between the CON group and the AMX group (2.9 ± 0.65 and 3.1 ± 0.98 h, respectively) (Fig. 2A). 237 
Generally, mink in both groups lost body mass during the study (Day -5 to Day 7), but no 238 
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difference was seen between groups (Table 1) and no significant difference in feed intake was 239 
observed during the intervention (Fig. 2B) or before treatment (data not shown).     240 
     In the present study, no apparent changes in histomorphological parameters related to neither the 241 
duodenum nor colon were seen between the two groups after the treatment (Table 1). Furthermore, 242 
no reaction in the mesenteric lymph nodes was recorded, and no difference in grading of hepatic 243 
steatosis was present between groups (data not shown).  244 
   Treatment with amoxicillin for 7 days had no significant influence on uptake of fat-soluble 245 
vitamins A and E, the level of acute phase reactant serum amyloid A, nor parameters related to 246 
lipolysis e.g. triglycerides and non-esterified fatty acids (data not shown), however, significantly 247 
higher levels of β-hydroxybutyrate was found in the AMX group on Day 7 (Fig. 2C). There were no 248 
differences between groups in the parameters included in the biochemical profile (data not shown).     249 
   A slight increase in digestibility of fat was seen in the group of mink receiving amoxicillin when 250 
compared to the control group during the treatment period (Fig. 2D-F). Data from one control mink 251 
in the digestibility trial was excluded from the study because of extremely abnormal values. 252 
 253 
Effects on the microbiota 254 
On Day -5 before the treatment period, no differences in the community composition of the faecal 255 
microbiota between the CON and AMX groups were observed (Fig. 3 and 4). Furthermore no 256 
differences in alpha diversity indices were found between groups before the intervention (Fig. 5) 257 
and also no separation of groups according to beta diversity was seen on Day -5 as assessed by 258 
PCoA analysis of unweighted UniFrac distances (Fig. 6). After two days of amoxicillin treatment 259 
(Day 2) the number of observed species in the AMX group was significantly higher than in the 260 
CON group (P<0.05), and the Shannon index was also higher although not significantly (Fig. 5A-261 
B). Principle coordinate analysis of beta diversity showed that faecal samples obtained from 262 
 12 
amoxicillin treated animals on Day 2 appeared to cluster together with feed samples and separate 263 
from the control animals (Fig. 6B), which is further supported by community composition 264 
histograms, where samples from the AMX group Day 2 and Feed samples appear very similar (Fig. 265 
3). On Day 2 the relative abundance of numerous bacterial genera were different between the CON 266 
and AMX groups (Fig. 4; Table S1, Supporting Information). 267 
   Analysis of mucus associated bacterial community obtained at the end of the treatment period 268 
(Day 7) revealed significantly lower alpha diversity in the AMX group compared to the CON group 269 
in terms of both number of observed species and Shannon diversity index (Fig. 5A-B) which 270 
appeared consistent with the community composition analysis based on relative abundance of 271 
bacterial classes (Fig. 3) as well as the separation of the two groups by PCoA (Fig. 6D). Three 272 
bacterial genera belonging to the Clostridia class, namely Clostridium sensu stricto, Anaerococcus 273 
and Clostridium XI, were found to have a lower relative abundance in the mucus layer in the AMX 274 
group compared to the CON group.  275 
   No faecal samples were obtained on Day 7; however, intestinal luminal samples were taken with 276 
disposable forceps directly from the distal part of the colon during the dissection. These samples 277 
appeared similar to mucus samples obtained on the same day in terms of bacterial composition (Fig. 278 
3). The same tendency is also seen in beta-diversity (principal coordinate analysis) where intestinal 279 
samples from Day 7 and mucosa samples from Day 7 appear to be similar (Fig. 6C-D), which may 280 
be due to the fact that the colon contained a sparse amount of luminal content making it difficult to 281 
avoid collecting mucus in those samples. For this reason, luminal samples obtained from Day 7 are 282 
not included in further analysis, as they are not deemed comparable to faecal sample taken on Day -283 
5 and Day 2. 284 
 285 
DISCUSSION 286 
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To our knowledge this is the first study to demonstrate that the intestinal microbial community 287 
composition of mink, changes considerably during treatment with amoxicillin. However, during the 288 
short-term intervention, no changes in parameters included in the biochemical profile, vitamin A 289 
and E levels, level of acute phase reactant serum amyloid A, parameters related to the general lipid 290 
metabolism nor histomorphological parameters related to the gut nor the liver were observed. The 291 
general loss in body mass observed in both groups may be due to a less intensive feeding strategy as 292 
well as stress factors during the study period.  293 
     No difference in GI-transit time was observed prior to the intervention and the community 294 
composition in the faecal microbiota between the two groups before the intervention did also not 295 
differ (Fig. 2, 3 and 4). Thus, the observed difference in microbiota composition during the 296 
administration of amoxicillin is a direct consequence of treatment. The early onset of changes in the 297 
gut microbiota after two days of treatment with amoxicillin is consistent with other studies 298 
(Cochetière et al. 2005). The observed increase in alpha diversity in the faecal microbiota after two 299 
days of treatment (Fig. 5) was surprising and not consistent with previous studies in dogs, rats and 300 
humans, which all show a significantly decreased microbial alpha diversity after treatment with β-301 
lactams and vancomycin (Grønvold et al. 2010; Panda et al. 2014; Vrieze et al. 2014; Tulstrup et al. 302 
2015). In the present study we find it very likely that the inhibitory effect of amoxicillin combined 303 
with the very fast intestinal transit time in mink and the high bacterial load associated with mink 304 
feed (Bahl et al. 2017) result in a population structure in faecal samples from amoxicillin treated 305 
animals comparable to that found in the feed. As mink feed has a relatively high microbial alpha 306 
diversity in terms of both number of observed species and Shannon diversity this results in an 307 
apparent increased count of observed species in these animals, which is thus a reflection of 308 
allochthonous microbes from the feed ingredients (Savage 1977). Interestingly, within the mucosa 309 
the amoxicillin treatment has the opposite effect of reducing the alpha diversity significantly (Fig. 310 
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5) which is consistent with other studies (Grønvold et al. 2010; Panda et al. 2014; Vrieze et al. 311 
2014; Tulstrup et al. 2015). Within the mucosa (Day 7) a couple of specific genera within the 312 
Clostridia were found to be affected by the amoxicillin treatment after correcting for multiple 313 
testing, which is supported by the global shift in community composition (Fig. 6D); however, a 314 
much more pronounced effect was found at the genera level in the faecal samples obtained on Day 315 
2 (Fig. 4). This supports the notion that genetic material detected in the faecal samples on Day 2 316 
(AMX group) is predominantly from feed-associated bacteria and thus not colonizing microbes. To 317 
investigate whether these bacteria are living or dead, a quantification of genetic material could have 318 
been applied as performed in other studies (Pérez-Cobas et al. 2012). The observed effects within 319 
the mucosa-associated bacteria (Fig. 3, 4 and 6) occur despite the very fast transit time in the 320 
gastrointestinal tract in mink (Bleavins and Aulerich 1981; Szymeczko and Skrede 1990) allowing 321 
limited time for uptake or direct effect of antimicrobials administered in the feed. The observed 322 
faecal microbiota in the mink may be partly driven by the resident bacterial community in the 323 
mucosa and partly by feed associated bacteria. We therefore speculate that the colonizing 324 
microbiota associated with the mucus layer is substantially inhibited by amoxicillin on Day 2 since 325 
the composition ingested appears similar to that detected in the faeces. An increased renewal of the 326 
colonic mucosa is essential given the fast transit time in the gastrointestinal tract. This is consistent 327 
with a recent study showing that a fast transit time is associated with an increased mucosal turnover 328 
in the gut and generally related to the bacterial composition and diversity (Roager et al. 2016). As 329 
there is a link between gastrointestinal-transit time and bacterial composition and diversity, it would 330 
have been interesting to have investigated transit time during the treatment period as well.  331 
     The elevated level of β-hydroxybutyrate in the AMX group could be caused by reduced appetite 332 
in this group even though no significant difference in feed intake was observed (Fig. 2). Fasting is 333 
known to induce lipolysis from adipose tissue and the formation of ketone bodies (VanItallie and 334 
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Nufert 2003); however, no alterations in triglycerides or non-esterified fatty acids were observed as 335 
would have been expected in the case of a physiological reaction to fasting (Mustonen et al. 2005; 336 
Rouvinen-Watt et al. 2010). 337 
   In the present study, no changes were seen in histomorphological parameters related the gut and 338 
the liver regarding characteristics of villus-crypt complex, goblet cells, crypt depth, thickness of 339 
tunica muscularis or grading of hepatic steatosis, respectively. A previous study with broilers, 340 
which are also characterised by having a fast GI-transit time (Ferrando et al. 1987), reported 341 
increased villus height and improved performance, in terms of significant weight gain after 342 
antibiotic growth promoter administration (Sayrafi et al. 2011).  343 
   Maintenance of the host barrier function in the gut is enhanced by the commensal bacterial 344 
community, which forms a colonization barrier by e.g. competitive metabolic interactions, 345 
occupying intestinal niches and induction of the host immune system (Kamada et al. 2013). 346 
Furthermore some metabolites, namely butyric acid, from the digestion of oligosaccharides serve as 347 
an important energy source for colonocytes (Wang et al. 2012) and modulate tight-junctions near 348 
the apical surface of epithelial cells (Ohata, Usami and Miyoshi 2005). A compromised barrier 349 
function may lead to the invasion of bacteria or bacterial by-product initiating an inflammatory 350 
response in the host. Results from the present study, however, did not show any increased levels of 351 
acute phase reactant serum amyloid A in the amoxicillin treated animals, which is a marker of 352 
inflammation (Jain, Gautam and Naseem 2011). 353 
   In broilers, antimicrobials have been shown to enhance apparent absorption of alpha-tocopheryl 354 
acetate (vitamin E) and fatty acids due to decreased deconjugation of bile acids by Clostridium 355 
perfringens (Knarreborg et al. 2004). In the current study, the amoxicillin treated animals showed a 356 
lower proportion of Clostridium sensu stricto (group containing C. perfringens) and a slightly 357 
higher digestibility with no effect on protein or carbohydrate digestibility nor the levels of vitamins 358 
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A and E. According to Hedemann et al. (Hedemann, Clausen and Jensen 2011) the biliary bile acids 359 
are exclusively taurine conjugated, but it is not known to which extent they are deconjugated by the 360 
gut microbiota. 361 
     It has been reported for laboratory rodents that antibiotic-induced perturbations of the intestinal 362 
microbiota may alter the host susceptibility to enteric infection (Stecher et al. 2007; Sekirov et al. 363 
2008; Endt et al. 2010). It would be of great practical relevance for the mink production to 364 
investigate whether the observed alterations in the gut microbiota following antimicrobial treatment 365 
in mink are associated with increased susceptibility to pathogens. This may especially be relevant in 366 
young animals. The current study contributes with useful information regarding experimental 367 
design for future studies within this field. Additionally, our findings may contribute to the 368 
understanding of gut health in other carnivorous animals subjected to antibiotic treatment.   369 
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 500 
Table S1. Relative abundance of bacterial groups at different taxonomical levels for individual 501 
animals at timepoints Day -5, Day 2, Day 7 as well as Mucus- and Feed samples. 502 
503 
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Figure legends: 504 
 505 
Fig. 1. Timeline of experimental period. The acclimatization period was from Day -7 to Day 0 and 506 
treatment period from Day 0 to Day 6. All animals were euthanized on Day 7. Blood samples (B) as 507 
well as faecal samples (F) and mucosal samples (M) were collected as indicated. Gastrointestinal 508 
transit time analysis (T) was performed on Day -4 and pathological examination (P) was performed 509 
during dissection. A digestibility trial (box) was performed from Day 0 to Day 4 during the 510 
treatment period.  511 
 512 
Fig. 2. Gastrointesinal transit time calculated at Day -4 (A), Percentage feed intake during the 513 
intervention calculated from Day 0-7 (B), serum β-hydroxybutyrate concentration determined on 514 
Day 7 (C) and digestibility of Fat (D), Protein (E) and Carbohydrate (F) during the intervention 515 
(Day 0-4). Boxplots show median and first and third quartile for the control group (CON, n=11-12), 516 
and the amoxicillin group (AMX, n=12) with whiskers indicating range. * P < 0.05. 517 
 518 
Fig. 3. Average bacterial community composition at the class level in faecal samples collected on 519 
Day -5, Day 2, and Day 7, as well as in mucus samples obtained on Day 7 for the control group 520 
(CON, n=12) and the amoxicillin group (AMX, n=11-12). The bacterial community composition in 521 
feed samples collected at the end of the study (Feed, n=5) is also shown.  522 
 523 
Fig. 4. Heatmap of z-scores calculated based on average relative abundance within each row for the 524 
control group (CON, n=12) and the group receiving amoxicillin (AMX, n=11-12) on Day -5, Day 2 525 
and mucus sample (Day 7). The bacterial genera depicted represent above 25% prevalence 526 
collectively in all samples. Asterisks indicate significant difference between the control group and 527 
the antibiotic treatment group compared at the same treatment time (FDR corrected permutation 528 
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based t-test). * P < 0.05, ** P < 0.01. The left-hand colour bar shows the taxonomic classification 529 
of bacterial genera at the class level (Orange: Actinobacteria, dark-green: Bacteroidia, light-gray: 530 
Flavobacteria, light-blue: Bacilli, blue: Clostridia, grey: Erysipelotrichia, dark-grey: Negativicutes, 531 
yellow: Fusobacteria, faint-pink: α-Proteobacteria, salmon: β-Proteobacteria, dark-red: χ-532 
Proteobacteria, red: γ-Proteobacteria and violet: Mollicutes. 533 
 534 
Fig. 5. Alpha-diversity of the bacterial communities in the faeces samples, mucosal scraps as well 535 
as feed samples. Bacterial richness (number of observed OTU’s) (A) and Shannon diversity index 536 
(B) are shown for faecal samples obtained on Day -5 and Day 2, mucus samples obtained post 537 
mortem on Day 7 as well as feed samples obtained at the end of study. Columns show mean values 538 
of the control group (CON, n=12), the amoxicillin group (AMX, n=12) as well as feed samples 539 
(Feed, n=5) with standard error of the means indicated by error bars. Significant differences 540 
between groups are indicated by asterisks * P < 0.05 and ** P < 0.01. 541 
 542 
Fig. 6. Beta-diversity represented as principle coordinate analysis based on un-weighted UniFrac 543 
distance matrix at Day -5 (A), during the treatment period at Day 2 (B), at the end of treatment at 544 
Day 7 (C) as well as mucusa associated microbiota samples collected post-mortem at Day 7 (D). 545 
Each dot represents a faecal- or mucus sample from individual animals in the control group (blue, 546 
n=12) and amoxicillin group (red, n=12). Feed samples obtained at the end of the study are also 547 
included (grey, n=5). 548 
 549 
  550 
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Tables 551 
 552 
Table 1. Animal body mass and histomorphological parameters of the intestine. 553 
 554 
 555 
 556 
 557 
 558 
 559 
 560 
 561 
 562 
 563 
 564 
 565 
 566 
aBody mass measured at day -5 and 7 respectively. bVillus-crypt complex measured from villus 567 
apex to the base of the crypt. cGoblet cells counted on a 400 µm piece of villus apex. Means ± 568 
SEM are shown. 569 
 570 
 Control group Amoxicillin group p-value 
Initial body mass (g)a 
Final body mass (g)a 
p-value 
2789 ± 93  
2661 ± 86  
<0.001 
2829 ± 83 
2652 ± 73  
<0.001 
0.75 
0.94 
 
Duodenum  
   Villus-crypt complex (µm)b 
   Goblet cellsc 
   Tunica muscularis (µm) 
Colon  
    Crypt depth (µm)  
    Tunica muscularis (µm) 
 
1053 ± 85.6 (n=12) 
27.1 ± 12.0 (n=12) 
413.3 ± 15.0 (n=10) 
 
459.5 ± 25.5 (n=12) 
932.7 ± 96.8 (n=10) 
 
1096 ± 76.2 (n=11) 
28.7 ± 12.3 (n=11) 
424 ± 30.8 (n=11) 
 
409.9 ± 20.2 (n=11) 
1117 ± 71.4 (n=12) 
 
0.78 
0.93 
0.75 
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0.13 
      -7   -6   -5   -4   -3   -2   -1    0        1        2        3    4           5      6        7 
CON 
AMX 
Control (CON) 
Amoxicillin (AMX) 
Time (days) 
n=12 
n=12 
   Acclimatization                Treatment 
F 
F 
T 
T 
F 
F 
M 
P 
M 
P 
Figure 1 
B 
B 
B 
B 
B 
B 
A B C
CON AMX
0
1
2
3
4
5
6
G
I-
tr
an
si
tt
im
e
(h
)
CON AMX
0
50
100
F
ee
d
in
ta
ke
(%
)
CON AMX
0.0
0.1
0.2
0.3
0.4
0.5
b-
hy
dr
ox
yb
ut
yr
at
e
(m
M
) *
Figure 2
CON AMX
60
65
70
75
80
Carbohydrate
D
ig
e
st
ib
ili
ty
(%
)
CON AMX
65
70
75
80
85
Protein
D
ig
e
st
ib
ili
ty
(%
)
CON AMX
90
95
100
D
ig
e
st
ib
ili
ty
(%
)
Fat
*
D E F
C
O
N
A
M
X
C
O
N
A
M
X
C
O
N
A
M
X
C
O
N
A
M
X
F
e
e
d
0.0
0.2
0.4
0.6
0.8
1.0
Day -5 Day 2  Day 7 Mucus
(Day 7)
Actinobacteria
Bacteroidia
Flavobacteriia
Sphingobacteriia
Bacilli
Clostridia
Erysipelotrichia
Negativicutes
Fusobacteriia
Alphaproteobacteria
Betaproteobacteria
Epsilonproteobacteria
Gammaproteobacteria
Spirochaetia
Mollicutes
Other
Figure 3
C
O
N
A
M
X
C
O
N
A
M
X
C
O
N
A
M
X
Actinomyces
Corynebacterium
Agrococcus
Clavibacter
Kocuria
Bacteroides
Alkaliflexus
Petrimonas
Porphyromonas
Bergeyella
Capnocytophaga
Myroides
Staphylococcus
Trichococcus
Enterococcus
Vagococcus
Lactobacillus
Weissella
Lactococcus
Streptococcus
Anaerobacter
Clostridium sensu stricto
Anaerococcus
Peptoniphilus
Anaerovorax
Anaerofustis
Pseudoramibacter
Clostridium XlVa
Clostridium XlVb
Lachnospiracea_incertae_sedis
Parasporobacterium
Pseudobutyrivibrio
Roseburia
Clostridium XI
Peptostreptococcus
Butyricicoccus
Ethanoligenens
Flavonifractor
Clostridium XVIII
Erysipelothrix
Erysipelotrichaceae_incertae_sedis
Turicibacter
Acidaminococcus
Cetobacterium
Clostridium XIX
Fusobacterium
Methylobacterium
Phyllobacterium
Ralstonia
Curvibacter
Pelomonas
Undibacterium
Neisseria
Uruburuella
Arcobacter
Aeromonas
Shewanella
Escherichia/Shigella
Morganella
Pantoea
Proteus
Marinospirillum
Actinobacillus
Haemophilus
Mannheimia
Pasteurella
Acinetobacter
Moraxella
Psychrobacter
Pseudomonas
Listonella
Wohlfahrtiimonas
Xanthomonas
Mycoplasma
row z-score
Color key
**
*
 Day -5      Day 2      Mucus
 (Day 7)
*
*
**
**
**
**
**
**
**
**
**
**
**
**
**
**
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
-1 0 1 2
Figure 4
C
O
N
A
M
X
C
O
N
A
M
X
C
O
N
A
M
X
F
ee
d
0
2
4
6
S
ha
nn
on
D
iv
er
si
ty
In
de
x p=0.07
Day -5        Day 2        Mucus
    (Day 7)
**
C
O
N
A
M
X
C
O
N
A
M
X
C
O
N
A
M
X
F
ee
d
0
50
100
150
200
#
O
bs
er
ve
d
sp
ec
ie
s
(O
T
U
s)
*
**
Day -5        Day 2        Mucus
    (Day 7)
Figure 5
A B
Day -5
-0.4 -0.2 0.0 0.2 0.4
-0.2
0.0
0.2
0.4
PC1 32.7%
P
C
2
2
6
.3
%
Day 2
-0.4 -0.2 0.0 0.2 0.4
-0.2
0.0
0.2
0.4
PC1 32.7%
P
C
2
2
6
,3
%
Mucus (Day 7)
-0.4 -0.2 0.0 0.2 0.4
-0.2
0.0
0.2
0.4 Control group
Amoxicillin group
Feed
PC1 32.7%
P
C
2
2
6
.3
%
Day 7
-0.4 -0.2 0.0 0.2 0.4
-0.2
0.0
0.2
0.4
PC1 32.7%
P
C
2
2
6
.3
%
Figure 6
A B
C D
